Arch Biopartners Appoints Claude Allary to Board of Directors
April 17, 2014 10:23 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwired - April 17, 2014) - Arch Biopartners Inc ("Arch" or the "Company") (CNSX:ACH)(OTCBB:FOIFF) announced today the board has appointed Claude Allary as an...
Arch Biopartners Enters Option to License University of Cincinnati Patent for Treating Bacterial Respiratory Infections
March 28, 2014 08:35 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwired - March 28, 2014) - Arch Biopartners Inc (Arch) or (the Company) (CSE:ACH)(OTCBB:FOIFF) announced today it has entered into a one year option agreement with...
Arch Biopartners Completes Private Placement
March 25, 2014 15:20 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwired - March 25, 2014) - Arch Biopartners Inc. ("Arch" or the "Company") (CNSX:ACH)(OTCBB:FOIFF) announced today it has raised $155,960 via a non-brokered...
Arch Biopartners Announcement
March 12, 2014 16:50 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwired - March 12, 2014) - With profound sadness, Arch Biopartners Inc. announces the passing of its Chairman, Jerry McElroy.
The Board and management will...
Arch Biopartners Completes Private Placement and Receives NRC Funding
February 25, 2014 10:46 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwired - Feb. 25, 2014) - Arch Biopartners Inc ("Arch" or the "Company") (CSE:ACH)(OTCBB:FOIFF) announced today it has raised $228,900 via a non-brokered private...
Arch Biopartners Completes Private Placement
February 25, 2014 08:55 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwired - Feb. 25, 2014) - Arch Biopartners Inc ("Arch" or the "Company") (CSE:ACH)(OTCBB:FOIFF) announced today it has raised $228,900 via a non-brokered private...
Brain Tumor Cell Targeting Technology: Data to Be Presented at the Society of Neuro-Oncology Quadrennial Meeting
November 20, 2013 09:10 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwired - Nov. 20, 2013) - Arch Biopartners Inc (Arch) or (the Company) (CNSX:ACH)(OTCBB:FOIFF) announced today that data relating to proprietary technology...
Arch Biopartners Announces Private Placement
October 21, 2013 07:00 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwired - Oct. 21, 2013) - Arch Biopartners Inc ("Arch" or the "Company")(CNSX:ACH)(OTCBB:FOIFF) is pleased to announce it has engaged M Partners Inc. (the "Agent")...
Arch Biopartners Appoints Former Roche Executives Patrick Smith and Craig Rayner as Drug Development Advisors
September 17, 2013 08:44 ET
|
Arch Biopartners Inc.
TORONTO, ONARIO--(Marketwired - Sept. 17, 2013) - Arch Biopartners Inc (Arch) or (the Company) (CNSX:ACH)(OTCBB:FOIFF) announced today Dr. Patrick Smith and Dr. Craig Rayner of d3...
Arch Biopartners Announces Issuance of U.S. Patent for Brain Tumor Cell Targeting Technology
September 12, 2013 09:02 ET
|
Arch Biopartners Inc.
TORONTO, ONTARIO--(Marketwired - Sept. 12, 2013) - Arch Biopartners Inc (Arch) or (the Company) (CNSX:ACH)(OTCBB:FOIFF) announced today that the U.S. Patent and Trademark Office has...